As of 23 September 2026, none of the research peptides searched on the FDA Philippines verification portal is registered, and 6 were not searched. Semaglutide and tirzepatide are registered only as branded prescription medicines (Ozempic, Wegovy, Rybelsus and Mounjaro). A research-grade vial is not a registered medicine.
Legal
Regulatory status by compound
For each compound this site covers: its status with FDA Philippines, the US FDA and the European Medicines Agency, each sourced and dated.
Short answer
Status by compound
| Compound | FDA Philippines | US FDA | EMA |
|---|---|---|---|
| Retatrutide | No registered drug product found on the FDA verification portal | Investigational | No record found |
| Tirzepatide | Registered only as the branded prescription medicine Mounjaro (12 certificates) | Approved for glycemic control in type 2 diabetes mellitus (Mounjaro); weight reduction in obesity or overweight with a comorbidity and moderate to severe obstructive sleep apnea in adults with obesity (Zepbound) | Approved for type 2 diabetes mellitus and weight management (Mounjaro) |
| Semaglutide | Registered only as branded prescription medicines: Ozempic, Wegovy and Rybelsus (17 certificates of product registration) | Approved for glycemic control in type 2 diabetes mellitus and related cardiovascular and kidney risk reduction (Ozempic, Rybelsus); chronic weight management and cardiovascular risk reduction in obesity or overweight (Wegovy) | Approved for type 2 diabetes mellitus (Ozempic, Rybelsus), weight management (Wegovy) and non-cirrhotic MASH with F2 to F3 fibrosis (Kayshild) |
| BPC-157 | No registered drug product found on the FDA verification portal | No record found | No record found |
| TB-500 | No registered drug product found on the FDA verification portal | No record found | No record found |
| GHK-Cu | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| KPV | No registration found; FDA Advisory No. 2026-1013 warns against an unregistered KPV product | No record found | No record found |
| NAD+ | No registration found; FDA Advisory No. 2025-0084 warns against an unregistered NAD product | No record found | No record found |
| MOTS-c | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| Tesamorelin | No registered drug product found on the FDA verification portal | Approved for reduction of excess abdominal fat in HIV-infected adult patients with lipodystrophy | Not approved |
| CJC-1295 | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| Ipamorelin | No registered drug product found on the FDA verification portal | No record found | No record found |
| Bremelanotide | Not published: the FDA verification portal was not searched for this name | Approved for acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women | No record found |
| Semax | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
| Selank | No registered drug product found on the FDA verification portal | No record found | No record found |
| DSIP | Not published: the FDA verification portal was not searched for this name | No record found | No record found |
Sources
US FDA and EMA columns: the regulatory dataset in the Research Desk of Primara Labs, our partner and supplier, which records the Drugs@FDA and EMA source and check date for every cell. FDA Philippines column: this site's search of the FDA verification portal on 23 September 2026, and the registration numbers in the GLP-1 price tracker. Each compound's page repeats its row with the source notes.
The regulation hub
- Are peptides legal in the Philippines?
- How FDA Philippines registration works, and what "not registered" means
- Prescription rules for GLP-1 medicines
- Bringing medicines or peptides into the Philippines
- Is selling peptides legal in the Philippines?
- FDA Philippines advisories on GLP-1s and peptides: timeline
Sources checked 23 September 2026. Primary sources only: statutes, DOH and FDA Philippines issuances, the FDA verification portal and the Bureau of Customs. This is general information, not legal advice.